These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 31199980

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Dissolution Mechanisms of Amorphous Solid Dispersions: Application of Ternary Phase Diagrams To Explain Release Behavior.
    Deac A, Luebbert C, Qi Q, Courtney RM, Indulkar AS, Gao Y, Zhang GGZ, Sadowski G, Taylor LS.
    Mol Pharm; 2024 Apr 01; 21(4):1900-1918. PubMed ID: 38469754
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Combined Effects of Supersaturation Rates and Doses on the Kinetic-Solubility Profiles of Amorphous Solid Dispersions Based on Water-Insoluble Poly(2-hydroxyethyl methacrylate) Hydrogels.
    Schver GCRM, Lee PI.
    Mol Pharm; 2018 May 07; 15(5):2017-2026. PubMed ID: 29601723
    [Abstract] [Full Text] [Related]

  • 26. Indomethacin-Kollidon VA64 Extrudates: A Mechanistic Study of pH-Dependent Controlled Release.
    Tres F, Treacher K, Booth J, Hughes LP, Wren SA, Aylott JW, Burley JC.
    Mol Pharm; 2016 Mar 07; 13(3):1166-75. PubMed ID: 26845251
    [Abstract] [Full Text] [Related]

  • 27. Effect of polymer hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture.
    Rumondor AC, Taylor LS.
    Mol Pharm; 2010 Apr 05; 7(2):477-90. PubMed ID: 20039693
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Viewing Molecular and Interface Interactions of Curcumin Amorphous Solid Dispersions for Comprehending Dissolution Mechanisms.
    Li J, Wang X, Li C, Fan N, Wang J, He Z, Sun J.
    Mol Pharm; 2017 Aug 07; 14(8):2781-2792. PubMed ID: 28661679
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions.
    Dengale SJ, Ranjan OP, Hussen SS, Krishna BS, Musmade PB, Gautham Shenoy G, Bhat K.
    Eur J Pharm Sci; 2014 Oct 01; 62():57-64. PubMed ID: 24878386
    [Abstract] [Full Text] [Related]

  • 33. Quantifying Molecular Mixing and Heterogeneity in Pharmaceutical Dispersions at Sub-100 nm Resolution by Spin Diffusion NMR.
    Duan P, Lamm MS, Yang F, Xu W, Skomski D, Su Y, Schmidt-Rohr K.
    Mol Pharm; 2020 Sep 08; 17(9):3567-3580. PubMed ID: 32787281
    [Abstract] [Full Text] [Related]

  • 34. The Combined Use of Imaging Approaches to Assess Drug Release from Multicomponent Solid Dispersions.
    Punčochová K, Ewing AV, Gajdošová M, Pekárek T, Beránek J, Kazarian SG, Štěpánek F.
    Pharm Res; 2017 May 08; 34(5):990-1001. PubMed ID: 27573574
    [Abstract] [Full Text] [Related]

  • 35. A Single Hydrogen to Fluorine Substitution Reverses the Trend of Surface Composition Enrichment of Sorafenib Amorphous Solid Dispersion upon Moisture Exposure.
    Chen Y, Chen H, Wang S, Liu C, Qian F.
    Pharm Res; 2019 May 17; 36(7):105. PubMed ID: 31102031
    [Abstract] [Full Text] [Related]

  • 36. Interdependence of particle properties and bulk powder behavior of indomethacin in quench-cooled molten two-phase solid dispersions.
    Semjonov K, Salm M, Lipiäinen T, Kogermann K, Lust A, Laidmäe I, Antikainen O, Strachan CJ, Ehlers H, Yliruusi J, Heinämäki J.
    Int J Pharm; 2018 Apr 25; 541(1-2):188-197. PubMed ID: 29481945
    [Abstract] [Full Text] [Related]

  • 37. Comparative study of the potential of poly(2-ethyl-2-oxazoline) as carrier in the formulation of amorphous solid dispersions of poorly soluble drugs.
    Boel E, Smeets A, Vergaelen M, De la Rosa VR, Hoogenboom R, Van den Mooter G.
    Eur J Pharm Biopharm; 2019 Nov 25; 144():79-90. PubMed ID: 31499162
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Phase separation in surfactant-containing amorphous solid dispersions: Orthogonal analytical methods to probe the effects of surfactants on morphology and phase composition.
    Yang R, Zhang GGZ, Kjoller K, Dillon E, Purohit HS, Taylor LS.
    Int J Pharm; 2022 May 10; 619():121708. PubMed ID: 35364219
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.